Neuroleptikabehandling vid schizofreni
- 1 January 1972
- journal article
- clinical trial
- Published by Taylor & Francis in Nordisk Psykiatrisk Tidsskrift
- Vol. 26 (6) , 323-340
- https://doi.org/10.3109/08039487209092073
Abstract
Denna översikt över neuroleptikabehandling vid schizofreni har författats av Göran Sedvall (bilden t.v.) som är biträdande professor i neuropsykofarmakologi vid Karolinska institutet och Henrik Nybäck (t.h.) som är docent i farmakologi vid Karolinska institutet.Keywords
This publication has 6 references indexed in Scilit:
- Discontinuation or reduction of chemotherapy in chronic schizophrenicsPublished by Elsevier ,2004
- Ergebnisse eines Doppelblindversuches von HF 1854*(8-Chlor-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b, e) (1,4) diazepin) im Vergleich zu LevomepromazinPharmacopsychiatry, 1971
- Drug Plasma Levels and Clinical Effect [Abridged]Proceedings of the Royal Society of Medicine, 1971
- Relapse in Chronic Schizophrenics following Abrupt Withdrawal of Tranquilizing MedicationThe British Journal of Psychiatry, 1969
- Plasma levels of chlorpromazine and some of its relatively non-polar metabolites in psychiatric patientsLife Sciences, 1967
- The pharmacological properties of a potent neurotropic compound from the dibenzothiazepine groupInternational Journal of Neuropharmacology, 1965